The attenuation of tumor progression in CD69 knockout mice was related to the increased levels of tumor infiltrating T cells and the decreased levels of CD8 T-cell exhaustion, and anti-CD69 antibody treatment enhanced the anti-tumor activity (Mita et al., 2018). This evidence concerns the gene CD69 and neoplasm.